🧬Immunotherapy / Immuno-Oncology
Market Cap$93.1B
1D-1.13%
Companies455
Public Cos81
SECTOR MARKET CAP
$93.1B-70.6%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | Germany | $23.6B | BNTX |
| 2 |  | China | $15.8B | 9926.HK |
| 3 |  | Denmark | $8.9B | ALK-B.CO |
| 4 |  | United States | $8.1B | IBRX |
| 5 |  | Japan | $7.4B | 4528.T |
| 6 |  | United States | $6.1B | CGON |
| 7 |  | United States | $1.6B | VIR |
| 8 |  | United Kingdom | $1.5B | IMCR |
| 9 |  | United States | $1.5B | BCAX |
| 10 |  | United States | $1.5B | IOVA |
| 11 |  | Germany | $1.5B | IMTX |
| 12 |  | United States | $1.5B | PGEN |
| 13 |  | Switzerland | $1.3B | MLTX |
| 14 |  | United States | $1.2B | ZBIO |
| 15 |  | France | $1.2B | DBVT |
| 16 |  | United Kingdom | $936.1M | AGY.L |
| 17 |  | United States | $911.4M | SLS |
| 18 |  | United States | $875.1M | VOR |
| 19 |  | United States | $863.8M | JANX |
| 20 |  | United States | $631.8M | CABA |